Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

COMBIMS

Financiado

Cerrado

A novel drug discovery method based on systems biology combination therapy and...

A novel drug discovery method based on systems biology combination therapy and biomarkers for Multiple Sclerosis The therapeutic challenge of complex diseases requires the use of combination therapies to target the distinct mechanisms and pathways involved. Such complex diseases will benefit from the design of computational models adopting a... ver más

31/12/2014

3M€

Presupuesto del proyecto: 3M€

Líder del proyecto

BIONURE FARMA SL No se ha especificado una descripción o un objeto social para esta compañía.

Fecha límite participación Sin fecha límite de participación.

Ver 7 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2014-12-31 No tenemos la información de la convocatoria

0% 77% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

7 Participantes

339.31K€ | Lider

566.60K€ | Participante

CONSORCI INSTITUT D INVESTIG...

162.32K€ | Participante

Protavio Ltd

516.88K€ | Participante

Proyectos interesantes

MIMIC

Medical Technol...

Data Science

163K€ Cerrado

ENLIGHT-TEN

Medical Technol...

Data Science

3M€ Cerrado

TopSpec

Medical Technol...

Data Science

4M€ Cerrado

IJC2018-037291-I

Medical Technol...

Data Science

93K€ Cerrado

GlycoX

Medical Technol...

Data Science

2M€ Cerrado

BES-2012-053653

Medical Technol...

Data Science

43K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

BIONURE FARMA SL No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 3M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The therapeutic challenge of complex diseases requires the use of combination therapies to target the distinct mechanisms and pathways involved. Such complex diseases will benefit from the design of computational models adopting a systems perspective to integrate the knowledge generated by ‘omics technologies and clinical data. Multiple Sclerosis is a prototypic debilitating complex disease in which an autoimmune attack is launched against the brain. Current therapies for MS are far from effective and target only part of the immune response. Hence, the need to develop combination therapies with good safety profiles that better control this condition, the main aim of CombMS. By understanding how current MS therapies work in biological networks and taking advantage of novel compounds, more effective combination therapies will be designed for MS. Indeed, the tools developed will be applicable to other immune and complex diseases to improve their therapeutic options in the future. The data for the modelling process will be generated from biological and clinical samples, and the predictions about combination therapies from the computational models tested using in vitro and animal models of MS. Given the limitations of animal models in translational research, we shall focus on studying the phosphoproteome in samples from individuals with MS (PBMC) using xMAP technology. The phosphoproteome has been identified as a system likely to be affected in MS and the novel therapeutic compounds that will be tested are known to act through signalling pathways involving receptor tyrosine kinases. The mechanistic modelling will be extended to the different levels of the response to therapy by analysing biological networks integrating gene and protein networks, with drugs, their effects and side-effects. As well as developing new combination therapies for MS, CombMS will provide proof of concept of the useful short term results that a systems biology drug discovery approach can provide.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores